Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)

NCT00541229 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: sitagliptin phosphate
DRUG: sitagliptin phosphate
DRUG: Comparator: Placebo

Sponsor

Merck Sharp & Dohme LLC